6 Articles
6 Articles
Semaclique, Germed's semiglutide pen, begins to be sold in Brazil for type 2 diabetes. See prices and indication.
Semaclique EMS A new Semaglutide pen produced in Brazil begins to be marketed on Friday (6). The medicine, called Semaclique, will be sold by Brace Pharma, company of the EMS Group, for R$ 464.81 a unit. In the purchase of three pens, the price falls to R$ 333 each, totaling R$ 999. The medicine was approved by the National Health Surveillance Agency (Anvisa) in August of this year for the treatment of adults with type 2 diabetes. Although Semag…
Marketed by the EMS Group, new pen arrives at the market after the end of the patent of semaglutide and expands the treatment options The post New slimming pen arrives at the pharmacies this Friday (6) for R$ 333 and brings novelty in the application apareceu primeiro em ND More
Five months after the release of Ozivy, the first Brazilian weight gainer pen based on semaglutide, the EMS Group begins, on Friday, November 6, the distribution of Semaclique, the version of the pharmaceutical medicine. The new pens will be distributed in all retail networks. About 450 representatives will also start the medical visits. [...] The post EMS brings to the shelves its third weight gainer pen and opens conversation with the SUS appe…
The national medicine is indicated for type 2 diabetes and has as active principle semaglutide, as well as Ozempic and Wegovy
Semaclique, a new slimming pen marketed by Brace Pharma, company of the EMS Group, arrives at the pharmacies on Friday (6). The drug will be sold for R$ 464.81 each unit or R$ 333 per unit in the purchase of a package with three pens, according to the company. Read more (11/06/2026
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
